2006 Immunization News
FDA Licenses New Vaccine for Prevention of Cervical Cancer and Other Diseases in Females Caused by Human Papillomavirus June 8
Merck's Gardasil approved for use in females 9–26 years of age.
FDA Licenses New Shingles Vaccine May 26
Merck's Zostavax licensed for use in people 60 and older.
Immunizations Rank among Cheapest, Most Effective Preventive Measures May 22
A recent Partnership for Prevention survey ranks childhood immunizations, the flu vaccine, and the pneumococcal vaccine among the top 10 most cost-effective preventive measures.
ACIP Issues Modified Temporary Recommendations for Menactra (Meningococcal Conjugate Vaccine) May 19
Because of limited supply of the vaccine, ACIP recommends not immunizing 11- and 12-year olds at this time.
National Immunization Project's April 2006 newsletter
Includes information on the restructuring of the NIP as the National Center for Immunization and Respiratory Diseases (NCIRD).
H5N1 Avian Flu Virus Vaccine Shows Promise March 29
An NIH article about the results of a clinical trial.
FDA Approves a Second Drug for the Prevention of Influenza A and B in Adults and Children March 29
An FDA news article with contact information.
NIP Expands Web-Based Training Course March 3
An online learning experience focused on immunization and vaccines.
FDA Approves New Vaccine to Prevent Rotavirus Gastroenteritis in Infants February 3
An FDA News article about RotaTeq and the study that showed it could be effective.